Steroid-free immunosuppression protocols

After your kidney transplant, you'll need to take several medications, including immunosuppressive medications, to keep your body's immune system from rejecting your new kidney. Mayo Clinic doctors prescribe many types of immunosuppressive (anti-rejection) medications, which may include steroid-free immunosuppression protocols.

In the past, people with kidney transplants usually have taken steroids (such as prednisone) as one of their immunosuppressive medications to prevent rejection. But steroids may cause weight gain, diabetes, high blood pressure, heart and blood vessel disease (cardiovascular disease), osteoporosis, and other problems.

You may be able to reduce or stop taking steroids soon after your kidney transplant, which may lessen your side effects and complications. You'll still need to take alternate immunosuppressive medications. Doctors will determine which drugs may be most appropriate for you based on your immune system risk, the specifics of your transplant, your reactions to medication side effects and other factors.

Mayo Clinic researchers continue to study steroid-free immunosuppression protocols and other potential immunosuppressive medication options for people with kidney transplants.

Sept. 11, 2018
References
  1. Scientific Registry of Transplant Recipients. http://www.srtr.org/default.aspx. Accessed April 7, 2016.
  2. U.S. News & World Report. U.S. News Best Hospitals 2015-16. http://health.usnews.com/best-hospitals/rankings. Accessed Feb. 22, 2016.
  3. Orandi BJ, et al. Kidney transplants from incompatible live donors. New England Journal of Medicine. 2016;374:940.
  4. Riggin EA. Allscripts EPSi. Mayo Clinic, Rochester, Minn. April 5, 2016.
  5. Schinstock CA (expert opinion). Mayo Clinic, Rochester, Minn. April 18, 2014.
  6. Lallas CD, et al. The development of a laparoscopic donor nephrectomy program in a de novo renal transplant program: Evolution of technique and results in over 200 cases. Journal of the Society of Laparoendoscopic Surgeons. 2006;10:135.
  7. Mai ML (expert opinion). Mayo Clinic, Jacksonville, Fla. April 26, 2016.
  8. Stulak JM, et al. Combined heart and abdominal organ transplantation: Excellent outcomes gained from a unique experience. Journal of Heart and Lung Transplantation. 2014;33:S278.
  9. Li H, et al. Assessing the efficacy of kidney paired donation — Performance of an integrated three-site program. Transplantation. 2014;98:300.
  10. Cornell LD, et al. Positive crossmatch kidney transplant recipients treated with eculizumab: Outcomes beyond 1 year. American Journal of Transplantation. 2015;15:1293.
  11. Shapiro R, et al. Benefits and complications of laparoscopic donor nephrectomy. http://www.uptodate.com/home. Accessed March 11, 2016.
  12. Polycystic kidney disease. National Institutes of Diabetes and Digestive Kidney Diseases. http://kidney.niddk.nih.gov/kudiseases/pubs/polycystic/. Accessed March 16, 2016.
  13. Raichlin E, et al. Combined heart and kidney transplantation provides an excellent survival and decreases risk of cardiac cellular rejection and coronary allograft vasculopathy. Transplantation Proceedings. 2011;43:1871.
  14. Heilman RL, et al. Steroid avoidance immunosuppression in low-risk kidney transplant recipients. Transplantation Proceedings. 2005;37:1785.
  15. Jay CL, et al. Reassessing preemptive kidney transplantation in the United States: Are we making progress? Transplantation. 20165;100:1120. http://www.transplantjournal.com. Accessed April 6, 2016.
  16. Bentall A, et al. Five-year outcomes in living donor kidney transplants with a positive crossmatch. American Journal of Transplantation. 2013;13:76.
  17. Prieto M (expert opinion). Mayo Clinic, Rochester, Minn. May 11, 2016.
  18. Dharnidharka VR, et al. Kidney transplantation in children. New England Journal of Medicine. 2014;371:549.
  19. Barbara Woodward Lips Patient Education Center. Your child's kidney transplant. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2016.
  20. Kidney transplant team describes current work. Mayovox. 1967;18:24.
  21. Kudva YC (expert opinion). Mayo Clinic, Rochester, Minn. March 14, 2016.
  22. Barbara Woodward Lips Patient Education Center. Kidney transplant. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2013.
  23. Rossi AP, et al. Evaluation of the potential renal transplant recipient. http://www.uptodate.com/home. Accessed April 6, 2016.
  24. Cramer CH II (expert opinion). Mayo Clinic, Rochester, Minn. April 27, 2016.
  25. Li H, et al. The limits of paired donation — Who doesn't get transplanted? American Journal of Transplantation. 2013;13(suppl 5). http://www.atcmeetingsabstracts.com/abstract/limits-of-paired-donation-who-doesn’t-get-transplanted-the/. Accessed April 27, 2016.
  26. Crespo HS, et al. Kidney transplantation in the septuagenarian. American Journal of Transplantation. 2015;15(suppl 3). http://www.atcmeetingabstracts.com/abstract/kidney-transplantation-in-the-septuagenarian/. Accessed April 27, 2016.
  27. Taner T, et al. Decreased chronic cellular and antibody-mediated injury in the kidney following simultaneous liver-kidney transplantation. Kidney International. 2016:89:909.